• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

I型转化生长因子β受体的转染可恢复胰腺癌中对转化生长因子β的反应性。

Transfection of the type I TGF-beta receptor restores TGF-beta responsiveness in pancreatic cancer.

作者信息

Wagner M, Kleeff J, Lopez M E, Bockman I, Massaqué J, Korc M

机构信息

Department of Medicine, University of California, Irvine 92697, USA.

出版信息

Int J Cancer. 1998 Oct 5;78(2):255-60. doi: 10.1002/(sici)1097-0215(19981005)78:2<255::aid-ijc21>3.0.co;2-8.

DOI:10.1002/(sici)1097-0215(19981005)78:2<255::aid-ijc21>3.0.co;2-8
PMID:9754660
Abstract

Transforming growth factor-beta (TGF-beta) signaling is initiated following heterodimerization of the type II TGF-beta receptor (TbetaRII) with the type I TGF-beta receptor (TbetaRI). Both receptors are required for TGF-beta responsiveness. In the present study, we characterized the actions of TGF-beta1 in T3M4 human pancreatic cancer cells, which express low levels of TbetaRI and high levels of TbetaRII. Cells were transiently transfected with p3TP-Lux, a TGF-beta-responsive luciferase reporter gene construct. TGF-beta1 was without effect in parental T3M4 cells, but caused a time- and dose-dependent increase in luciferase activity in T3M4 cells co-transfected with a TbetaRI cDNA expression vector. Co-transfection of TbetaRI with a truncated Smad4 cDNA that is known to block TGF-beta-dependent signaling, abrogated the TbetaRI-induced increase in luciferase activity. Sequencing of the TbetaRI and the Smad4 genes in T3M4 cells did not reveal any mutations. These findings indicate that one mechanism for TGF-beta resistance in pancreatic cancer is due to a quantitative decrease in TbetaRI expression.

摘要

转化生长因子-β(TGF-β)信号转导在II型TGF-β受体(TβRII)与I型TGF-β受体(TβRI)异源二聚化后启动。两种受体对于TGF-β反应性都是必需的。在本研究中,我们表征了TGF-β1在T3M4人胰腺癌细胞中的作用,这些细胞表达低水平的TβRI和高水平的TβRII。用p3TP-Lux(一种TGF-β反应性荧光素酶报告基因构建体)对细胞进行瞬时转染。TGF-β1对亲本T3M4细胞没有作用,但在与TβRI cDNA表达载体共转染的T3M4细胞中导致荧光素酶活性呈时间和剂量依赖性增加。将TβRI与已知可阻断TGF-β依赖性信号转导的截短型Smad4 cDNA共转染,消除了TβRI诱导的荧光素酶活性增加。对T3M4细胞中的TβRI和Smad4基因进行测序未发现任何突变。这些发现表明胰腺癌中TGF-β抗性的一种机制是由于TβRI表达的定量减少。

相似文献

1
Transfection of the type I TGF-beta receptor restores TGF-beta responsiveness in pancreatic cancer.I型转化生长因子β受体的转染可恢复胰腺癌中对转化生长因子β的反应性。
Int J Cancer. 1998 Oct 5;78(2):255-60. doi: 10.1002/(sici)1097-0215(19981005)78:2<255::aid-ijc21>3.0.co;2-8.
2
Lack of responsiveness to TGF-beta1 in a thyroid carcinoma cell line with functional type I and type II TGF-beta receptors and Smad proteins, suggests a novel mechanism for TGF-beta insensitivity in carcinoma cells.在具有功能性I型和II型转化生长因子β(TGF-β)受体以及Smad蛋白的甲状腺癌细胞系中,对TGF-β1缺乏反应性,提示癌细胞中TGF-β不敏感的一种新机制。
Mol Cell Endocrinol. 1999 Jul 20;153(1-2):79-90. doi: 10.1016/s0303-7207(99)00086-6.
3
Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.转化生长因子β受体在人胰腺腺癌中的差异表达
Anticancer Res. 2000 Jan-Feb;20(1A):43-51.
4
Overexpression of transforming growth factor beta type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line.转化生长因子β I 型受体的过表达消除了大鼠膀胱癌细胞系的恶性表型。
Cell Growth Differ. 1997 Aug;8(8):921-6.
5
Transforming growth factor-beta induces formation of a dithiothreitol-resistant type I/Type II receptor complex in live cells.转化生长因子-β诱导活细胞中形成对二硫苏糖醇有抗性的I型/II型受体复合物。
J Biol Chem. 1999 Feb 26;274(9):5716-22. doi: 10.1074/jbc.274.9.5716.
6
TGF-beta-1 up-regulates cyclin D1 expression in COLO-357 cells, whereas suppression of cyclin D1 levels is associated with down-regulation of the type I TGF-beta receptor.转化生长因子-β1(TGF-β1)上调COLO-357细胞中细胞周期蛋白D1的表达,而细胞周期蛋白D1水平的抑制与I型TGF-β受体的下调相关。
Int J Cancer. 1999 Oct 8;83(2):247-54. doi: 10.1002/(sici)1097-0215(19991008)83:2<247::aid-ijc17>3.0.co;2-0.
7
Ligand induced upregulation of the type II transforming growth factor (TGF-beta) receptor enhances TGF-beta responsiveness in COLO-357 cells.配体诱导的II型转化生长因子(TGF-β)受体上调增强了COLO-357细胞中TGF-β的反应性。
Pancreas. 1999 May;18(4):364-70. doi: 10.1097/00006676-199905000-00006.
8
Ovarian transforming growth factor-beta (TGF-beta) receptors: in-vitro effects of follicle stimulating hormone, epidermal growth factor and TGF-beta on receptor expression in human preantral follicles.卵巢转化生长因子-β(TGF-β)受体:促卵泡激素、表皮生长因子和TGF-β对人窦前卵泡受体表达的体外影响
Mol Hum Reprod. 1998 Mar;4(3):207-14. doi: 10.1093/molehr/4.3.207.
9
Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.转化生长因子β信号传导在人类子宫内膜癌发生早期即被破坏,同时伴随着生长抑制的丧失。
Cancer Res. 2002 May 15;62(10):2778-90.
10
A pivotal role for the transmembrane domain in transforming growth factor-beta receptor activation.跨膜结构域在转化生长因子-β受体激活中的关键作用。
J Biol Chem. 1999 Apr 23;274(17):11773-81. doi: 10.1074/jbc.274.17.11773.

引用本文的文献

1
Review and Application of Integrin Alpha v Beta 6 in the Diagnosis and Treatment of Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma.整合素 αvβ6 在胆管癌和胰腺导管腺癌诊断和治疗中的回顾与应用。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231189399. doi: 10.1177/15330338231189399.
2
Successful Immunotherapy for Pancreatic Cancer in a Patient With TSC2 and SMAD4 Mutations: A Case Report.TSC2 和 SMAD4 突变患者的胰腺癌免疫治疗成功:病例报告。
Front Immunol. 2021 Nov 22;12:785400. doi: 10.3389/fimmu.2021.785400. eCollection 2021.
3
SMURF1 and SMURF2 in Progenitor Cells from Articular Cartilage and Meniscus during Late-Stage Osteoarthritis.
SMURF1 和 SMURF2 在晚期骨关节炎关节软骨和半月板祖细胞中的表达。
Cartilage. 2021 Dec;13(2_suppl):117S-128S. doi: 10.1177/1947603520967069. Epub 2020 Oct 22.
4
The TGF-β/Smad4 Signaling Pathway in Pancreatic Carcinogenesis and Its Clinical Significance.转化生长因子-β/ Smad4信号通路在胰腺癌发生中的作用及其临床意义
J Clin Med. 2017 Jan 5;6(1):5. doi: 10.3390/jcm6010005.
5
Single and Multiple Gene Manipulations in Mouse Models of Human Cancer.人类癌症小鼠模型中的单基因和多基因操作
Cancer Growth Metastasis. 2015 Jul 13;8(Suppl 1):1-15. doi: 10.4137/CGM.S21217. eCollection 2015.
6
SMAD4 and its role in pancreatic cancer.SMAD4 及其在胰腺癌中的作用。
Tumour Biol. 2015 Jan;36(1):111-9. doi: 10.1007/s13277-014-2883-z. Epub 2014 Dec 3.
7
Gatifloxacin induces S and G2-phase cell cycle arrest in pancreatic cancer cells via p21/p27/p53.加替沙星通过 p21/p27/p53 诱导胰腺癌 S 和 G2 期细胞周期停滞。
PLoS One. 2012;7(10):e47796. doi: 10.1371/journal.pone.0047796. Epub 2012 Oct 25.
8
AGR2 is a SMAD4-suppressible gene that modulates MUC1 levels and promotes the initiation and progression of pancreatic intraepithelial neoplasia.AGR2 是一个可被 SMAD4 抑制的基因,可调节 MUC1 水平,并促进胰腺上皮内瘤变的发生和进展。
Oncogene. 2013 Aug 15;32(33):3867-76. doi: 10.1038/onc.2012.394. Epub 2012 Sep 3.
9
Concomitant targeting of EGF receptor, TGF-beta and SRC points to a novel therapeutic approach in pancreatic cancer.联合靶向表皮生长因子受体、转化生长因子-β 和 SRC 为胰腺癌的治疗提供了一种新的方法。
PLoS One. 2012;7(6):e39684. doi: 10.1371/journal.pone.0039684. Epub 2012 Jun 27.
10
A control engineering approach to understanding the TGF-β paradox in cancer.从控制工程角度理解癌症中 TGF-β 悖论。
J R Soc Interface. 2012 Jun 7;9(71):1389-97. doi: 10.1098/rsif.2011.0799. Epub 2011 Dec 21.